相关实验视频
Updated: Sep 19, 2025

05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
2.9K
SFXN1通过抑制PINK1依赖的线粒细胞吸收来促进膀癌转移
Baochao Zhang1, Guanqun Dong2, Xinyue Guo3
1Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Oncogene
|June 4, 2025
概括
西德罗素1 (SFXN1) 驱动膀癌 (BLCA) 转移通过抑制线粒细胞衰变,而不是血清运输. 准SFXN1通过恢复线粒细胞衰变为BLCA提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 赛德罗素1 (SFXN1) 是一种线粒体血清载体,在瘤发育中具有潜在的作用.
- 在膀癌 (BLCA) 中SFXN1的功能及其潜在机制在很大程度上仍未被探索.
研究的目的:
- 研究SFXN1在膀癌 (BLCA) 进展中的作用和机制.
- 确定SFXN1作为BLCA的潜在治疗点.
主要方法:
- 在临床BLCA组织中分析SFXN1表达.
- 在体外和体外实验评估SFXN1缺乏对BLCA细胞增殖和转移的影响.
- 研究SFXN1与PINK1 (PTEN诱导激酶1) 依赖的线粒,PARL和MPP-β的相互作用.
- 评估线粒体活性氧物种 (mtROS) 和TGF-β (转化生长因子-β) 介导的上皮细胞-介质细胞过渡 (EMT).
主要成果:
- 在BLCA组织中,SFXN1被上调,并与预后不佳有关.
- 缺少SFXN1抑制BLCA细胞的增殖和转移.
- SFXN1通过与PARL和MPP-β的相互作用促进PINK1降解来抑制PINK1依赖的线粒细胞衰变.
- SFXN1诱导的线粒停止导致mtROS积累,激活TGF-β介导的EMT并促进BLCA转移.
结论:
- SFXN1在BLCA中起着致癌作用,通过抑制线粒细胞衰变促进转移.
- SFXN1代表了膀癌的新型治疗点.
- 这项研究揭示了在BLCA进展中菌体,mtROS和EMT之间的新机制.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.4K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.3K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K